dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Barrecheguren Fernández, Miriam |
dc.contributor.author | Solntseva, Iryna |
dc.contributor.author | Dhalwani, Nafeesa |
dc.contributor.author | Booth, Alison |
dc.contributor.author | Nuñez Dubon, Alexa Gabriela |
dc.contributor.author | Miravitlles Fernández, Marc |
dc.contributor.author | Monteagudo, Mònica |
dc.date.accessioned | 2021-11-15T09:41:45Z |
dc.date.available | 2021-11-15T09:41:45Z |
dc.date.issued | 2021-03-22 |
dc.identifier.citation | Monteagudo M, Barrecheguren M, Solntseva I, Dhalwani N, Booth A, Nuñez A, et al. Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD. NPJ Prim Care Respir Med. 2021 Mar 22;31:16. |
dc.identifier.issn | 2055-1010 |
dc.identifier.uri | https://hdl.handle.net/11351/6540 |
dc.description | Chronic obstructive pulmonary disease; Epidemiology |
dc.description.abstract | There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalonia from 2011 to 2015 aimed to identify the use of TT in patients with newly diagnosed COPD. A total of 69,668 newly diagnosed patients were identified of whom 11,524 (16.5%) initiated TT, of whom 8626 initiated TT at or immediately after COPD diagnosis. Among them, 72.3% were GOLD A/B, 14.6% were frequent exacerbators, and 7.1% had asthma–COPD overlap (ACO). Variables associated with TT initiation were: male sex, older age, previous exacerbations, ACO, a previous treatment regimen containing an inhaled corticosteroid, previous pneumonia, and history of lung cancer. A significant number of COPD patients in Primary Care initiated TT shortly after or even before an established COPD diagnosis. |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | NPJ Primary Care Respiratory Medicine;31 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Malalties obstructives - Tractament |
dc.subject | Pulmons - Malalties obstructives - Diagnòstic |
dc.subject.mesh | Pulmonary Disease, Chronic Obstructive |
dc.subject.mesh | /diagnosis |
dc.subject.mesh | Drug Therapy, Combination |
dc.title | Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41533-021-00227-x |
dc.subject.decs | enfermedad pulmonar obstructiva crónica |
dc.subject.decs | /diagnóstico |
dc.subject.decs | farmacoterapia combinada |
dc.relation.publishversion | https://doi.org/10.1038/s41533-021-00227-x |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Monteagudo M] Primary Care University Research Institute Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Barrecheguren M] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain. [Solntseva I] Primary Care University Research Institute Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain. [Dhalwani N, Booth A] Evidera, London, UK. [Nuñez A, Miravitlles M] Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain |
dc.identifier.pmid | 33753747 |
dc.identifier.wos | 000632053400001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |